相关实验视频
Updated: Sep 12, 2025

05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
18.0K
简要报告:转向长期作用的CAB/RPV:来自意大利单心系群的数据
Maddalena Matone1, Marco Piscaglia1,2, Andrea Giacomelli3
1Department of Infectious Diseases, Unit I, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy.
Journal of acquired immune deficiency syndromes (1999)
|August 8, 2025
概括
卡博特格拉维尔/里尔皮维林 (CAB/RPV) 长效注射疗法在HIV-1患者中显示出高坚持性和良好的耐受性. 停药率很低,主要是由于注射部位疼痛,没有确定的病毒学失败.
科学领域:
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
- 艾滋病毒/艾滋病 治疗
背景情况:
- 卡博特格拉维尔/里尔皮维林 (CAB/RPV) 是第一个长效注射抗逆转录病毒疗法 (LAI),用于HIV-1病毒抑制的成年人.
- 这项研究评估了每8周 (Q8W) 服用一次CAB/RPV LAI的现实结果.
研究的目的:
- 在临床环境中评估CAB/RPV LAI的耐用性和坚持性.
- 为了确定停止治疗的原因.
- 为了评估CAB/RPV LAI治疗期间的病毒学结果.
主要方法:
- 一个单一中心的意大利队列的回顾性观察研究.
- 包括138名在CAB/RPV LAI Q8W上的HIV-1患者.
- 平均观察期为43周.
主要成果:
- 对注射计划的高度遵守 (92.8%).
- 停药率低 (8.7%),注射部位疼痛是最常见的原因.
- 没有观察到确定的病毒学失败;3名患者经历了病毒学闪现.
结论:
- 在临床实践中,CAB/RPV LAI Q8W 耐受性很好.
- 高的坚持率和低的戒断率支持其使用.
- 注射部位疼痛是停止治疗的可控原因.
相关概念视频
Pharmacovigilance
993
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
993
Longitudinal Studies
247
Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
247
Clinical Trials
8.3K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.3K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Retroviruses
12.7K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.7K
Analysis of Population Pharmacokinetic Data
383
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
383

